GlassScriptPhysician profile
Mackenzie D Lawson
NPI 1568050177
$14,585.85
in general payments reported to CMS, 2019-2025
56 companies · $2,156 in 2025
The $2,156 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,813 · 2022: $3,638 · 2023: $2,702 · 2024: $4,277 · 2025: $2,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,951 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,950.85 |
| Education | $183.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,931.89 | 2021-2025 | |
| Livanova USA, INC. | $1,638.25 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $1,013.27 | 2021-2025 | Briviact, Nayzilam, Rystiggo |
| Neurocrine Biosciences, INC. | $867.03 | 2021-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $664.70 | 2021-2025 | Kisunla, Emgality, Amyvid |
| Teva Pharmaceuticals USA, INC. | $633.00 | 2021-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Mdd US Operations, LLC | $630.63 | 2022-2025 | Apokyn, Apokyn |
| Sk Life Science, INC. | $619.31 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $595.07 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $557.27 | 2021-2025 | Crexont, Rytary, Ongentys |
| Biogen, INC. | $472.90 | 2021-2024 | Vumerity, Tysabri, Avonex |
| Alexion Pharmaceuticals, INC. | $437.69 | 2021-2025 | Ultomiris, Soliris |
| Eisai INC. | $380.24 | 2021-2025 | |
| Amgen INC. | $307.63 | 2022-2024 | Uplizna, Aimovig |
| Lundbeck LLC | $280.99 | 2021-2025 | Vyepti |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Lawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.